Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Lloyd-Smith Malcolm

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Integration OfficerFeb 06, 2023Sale$105.8280184,75829,300Feb 08, 2023, 07:35 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Integration OfficerFeb 07, 2023Sale$102.3913,8161,414,65441,710Feb 08, 2023, 07:35 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Integration OfficerFeb 08, 2023Sale$103.8370172,78542,337Feb 08, 2023, 07:35 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Integration OfficerJan 31, 2023Sale$110.021,666183,29028,582Feb 02, 2023, 05:24 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerAug 15, 2022Option Exercise$45.968,043369,66326,931Aug 16, 2022, 06:44 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerAug 12, 2022Option Exercise$70.9743,0663,056,30840,421Aug 16, 2022, 06:44 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 07, 2022Sale$80.722,681216,41718,104Feb 09, 2022, 07:04 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 08, 2022Sale$79.5370155,75118,731Feb 09, 2022, 07:04 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerJul 27, 2021Sale$93.8016,7091,567,33615,801Jul 29, 2021, 05:32 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 10, 2021Sale$77.973,400265,10833,610Feb 12, 2021, 08:27 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 05, 2021Sale$114.1586598,73929,675Feb 09, 2021, 09:20 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 08, 2021Sale$116.813,261380,92832,510Feb 09, 2021, 09:20 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerJan 25, 2021Option Exercise$77.2135,1402,713,28437,960Jan 27, 2021, 09:30 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerJan 26, 2021Option Exercise$77.982,200171,55529,602Jan 27, 2021, 09:30 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerNov 12, 2020Sale$90.732,257204,77629,002Nov 16, 2020, 06:21 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerAug 05, 2020Sale$118.862,257268,27826,971Aug 07, 2020, 07:47 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerApr 24, 2020Sale$99.451,934192,32924,941Apr 28, 2020, 08:44 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 07, 2020Sale$103.281,015104,82623,200Feb 11, 2020, 07:21 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 10, 2020Sale$82.1157,9384,757,23239,127Feb 11, 2020, 07:21 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 05, 2020Sale$103.051,948200,73421,127Feb 07, 2020, 06:47 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 06, 2020Sale$101.511,490151,25722,287Feb 07, 2020, 06:47 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerOct 14, 2019Option Exercise$53.1519,9121,058,30729,569Oct 16, 2019, 04:20 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 06, 2019Sale$83.5892076,89419,238Feb 08, 2019, 05:11 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 05, 2019Sale$88.141,272112,11917,508Feb 06, 2019, 06:06 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerNov 06, 2018Sale$62.7311,400715,16221,018Nov 08, 2018, 05:03 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerNov 07, 2018Sale$62.726,600413,98518,618Nov 08, 2018, 05:03 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 05, 2018Sale$83.1996079,86313,982Feb 07, 2018, 06:07 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 06, 2018Option Exercise$82.481,314108,37915,318Feb 07, 2018, 06:07 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerJan 02, 2018Sale$46.4836,1681,681,22131,101Jan 04, 2018, 04:05 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerMay 18, 2017Option Exercise$34.359,960342,17617,997May 23, 2017, 04:34 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerMay 19, 2017Sale$34.729,960345,86117,997May 23, 2017, 04:34 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerApr 12, 2017Sale$50.4213,065658,77413,221Apr 13, 2017, 04:56 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 06, 2017Sale$43.1572731,3700Feb 08, 2017, 07:41 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerFeb 07, 2017Sale$44.611165,1751,082Feb 08, 2017, 07:41 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerSep 01, 2016Option Exercise$32.7218,000589,0509,000Sep 02, 2016, 03:26 PM
NBIXNEUROCRINE BIOSCIENCES INCLloyd-Smith MalcolmChief Regulatory OfficerMay 31, 2016Option Exercise$32.7218,000589,0509,000Jun 02, 2016, 04:03 PM
CADXCADENCE PHARMACEUTICALS INCLloyd-Smith MalcolmSVP, Reg Affairs, Qual & ClinMar 19, 2014Option Exercise$14.002,33232,6480Mar 21, 2014, 01:26 PM
CADXCADENCE PHARMACEUTICALS INCLloyd-Smith MalcolmSVP, Reg Affairs, Qual & ClinJul 22, 2013Sale$5.6828,000159,04016,332Jul 23, 2013, 07:00 PM
CADXCADENCE PHARMACEUTICALS INCLloyd-Smith MalcolmSVP, Reg Affairs, Qual & ClinJun 10, 2013Sale$7.444,00029,7602,332Jun 11, 2013, 05:15 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe